A Clinical Trial Evaluating TG4050 in Head and Neck Cancer

Recruiting

Phase 1

Phase 2

TG4050A Clinical Trial Evaluating TG4050 in Head and Neck Cancer

Sponsor:

Transgene

Code:

NCT04183166

Conditions

Squamous Cell Carcinoma of Head and Neck

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TG4050

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Transgene on 2025-03-19.